Superworth

Opko Health price to book ratio OPK

Market value divided by the book value of the company's net assets, since 2011.

Today, Oct 23, 2026
1.0×
10-year median
0.9×
Against its 10-year history
57th
percentile: 0 is its lowest day, 100 its highest
10-year range
0.4× to 3.2×
Peer median
2.4×

Opko Health's price to book ratio is 1.0× as of Oct 23, 2026.

That is above its ten-year median of 0.9×, close to the middle of its last ten years.

Over that time it ranged from 0.4× in Mar 2024 to 3.2× in Dec 2016.

The median for 10 large drugmakers of a similar size is 2.4×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far1.0×0.7×1.1×
20250.8×0.7×1.0×
20240.7×0.4×0.8×
20230.8×0.5×1.1×
20220.6×0.5×1.7×
20211.9×1.3×2.3×
20201.6×0.5×2.4×
20190.6×0.5×1.2×
20181.0×0.8×1.8×
20171.3×1.3×2.5×
20162.5×2.2×3.2×
20152.8×2.8×9.9×
20144.7×3.6×4.7×
20134.0×4.0×16.0×
20129.6×8.0×15.0×
201113.9×9.4×15.2×

Against its peers

Companies in Drug Manufacturers - General nearest Opko Health's size, closest first, today.

CompanyPrice to book ratio
OPKOpko Health1.0×
OMEROmerosn/m
AMPHAmphastar Pharmaceuticals1.4×
PCRXPacira BioSciences2.2×
ANABAnaptysbio138×
PAHCPhibro Animal Health4.1×
ANIPANI Pharmaceuticals2.8×
ABUSArbutus Biopharma3.2×
COLLCollegium Pharmaceutical2.4×
HRMYHarmony Biosciences2.1×
PBHPrestige Consumer Healthcare1.2×
Peer median2.4×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Opko Health

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.